Hunan Fangsheng Pharm Co Ltd Total Liabilities
Hunan Fangsheng Pharm Co Ltd total liabilities. Based on the latest financial reports, Hunan Fangsheng Pharm Co Ltd (603998) has total liabilities worth CN¥1.22 Billion CNY (≈ $179.02 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Hunan Fangsheng Pharm Co Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Hunan Fangsheng Pharm Co Ltd (2011–2025)
Total liabilities of Hunan Fangsheng Pharm Co Ltd from 2011 to 2025. This chart illustrates how Hunan Fangsheng Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 603998 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Hunan Fangsheng Pharm Co Ltd Competitors by Total Liabilities
The table below lists competitors of Hunan Fangsheng Pharm Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shenzhen Jinjia Color Printing Group Co Ltd
SHE:002191
|
China | CN¥1.48 Billion |
|
Ningxia Xinri Hengli Steel Wire Rope Co Ltd
SHG:600165
|
China | CN¥1.14 Billion |
|
Ncs Testing Technology Co Ltd
SHE:300797
|
China | CN¥976.21 Million |
|
Burelle SA
PA:BUR
|
France | €5.68 Billion |
|
Obsidian Energy Ltd
TO:OBE
|
Canada | CA$640.40 Million |
|
SHENWAN HONGYUAN GR.H YC1
F:2X2A
|
Germany | €620.89 Billion |
|
Shore Bancshares Inc
NASDAQ:SHBI
|
USA | $5.67 Billion |
|
Cita Mineral Investindo Tbk PT
JK:CITA
|
Indonesia | Rp338.73 Billion |
Liability Composition Analysis (2011–2025)
This chart breaks down Hunan Fangsheng Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 603998 total asset value.
Liquidity & Leverage Metrics
Hunan Fangsheng Pharm Co Ltd Total Liabilities Ratios Explained
Hunan Fangsheng Pharm Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.95 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.69 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hunan Fangsheng Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hunan Fangsheng Pharm Co Ltd (2011–2025)
The table below shows the annual total liabilities of Hunan Fangsheng Pharm Co Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.25 Billion ≈ $183.35 Million |
-18.20% |
| 2024-12-31 | CN¥1.53 Billion ≈ $224.14 Million |
+2.64% |
| 2023-12-31 | CN¥1.49 Billion ≈ $218.36 Million |
+5.52% |
| 2022-12-31 | CN¥1.41 Billion ≈ $206.94 Million |
+0.95% |
| 2021-12-31 | CN¥1.40 Billion ≈ $204.99 Million |
+43.37% |
| 2020-12-31 | CN¥977.05 Million ≈ $142.97 Million |
+23.29% |
| 2019-12-31 | CN¥792.51 Million ≈ $115.97 Million |
+49.58% |
| 2018-12-31 | CN¥529.81 Million ≈ $77.53 Million |
+57.97% |
| 2017-12-31 | CN¥335.39 Million ≈ $49.08 Million |
+15.13% |
| 2016-12-31 | CN¥291.31 Million ≈ $42.63 Million |
+115.88% |
| 2015-12-31 | CN¥134.94 Million ≈ $19.75 Million |
+56.03% |
| 2014-12-31 | CN¥86.48 Million ≈ $12.66 Million |
+8.79% |
| 2013-12-31 | CN¥79.50 Million ≈ $11.63 Million |
+39.51% |
| 2012-12-31 | CN¥56.98 Million ≈ $8.34 Million |
-17.28% |
| 2011-12-31 | CN¥68.89 Million ≈ $10.08 Million |
-- |
About Hunan Fangsheng Pharm Co Ltd
Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, neurological drugs, gynecological … Read more